Logotype for Terumo Corporation

Terumo (4543) investor relations material

Terumo M&A Announcement summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Terumo Corporation
M&A Announcement summary27 Aug, 2025

Deal rationale and strategic fit

  • Acquisition enables entry into the high-growth organ transplantation market, addressing significant unmet needs in organ preservation and transplantation globally, especially for livers and kidneys.

  • The target's innovative normothermic perfusion technology extends organ preservation time, improves transplant outcomes, and expands the donor pool.

  • The deal aligns with a strategy to achieve leapfrog growth, diversify beyond existing business domains, and enhance corporate value through unique synergies.

  • Supports portfolio enhancement and accelerated growth, with management confident in rare alignment with all strategic criteria.

  • Seeks to address challenges such as organ shortages, improve utilization rates, and enable use of marginal donor organs.

Financial terms and conditions

  • 100% of the target's outstanding shares will be acquired for approximately $1.5 billion in cash, subject to adjustments for cash, debt, and working capital.

  • Funded by cash on hand, borrowings, and debt, maintaining a healthy balance sheet post-acquisition.

  • The agreement was signed on August 23, 2025, with closing targeted within the fiscal year, subject to regulatory approvals.

  • The acquisition is expected to be accretive to adjusted operating profit and earnings per share from the next fiscal year, excluding special factors.

  • OrganOx will become a wholly owned subsidiary upon completion.

Synergies and expected cost savings

  • Synergies expected from combining advanced perfusion and monitoring technologies, leveraging manufacturing, R&D, and global infrastructure.

  • Integration will enable use of proprietary components and expand post-transplant care offerings.

  • Cost synergies anticipated through shared manufacturing facilities and operational efficiencies.

  • Enables creation of new solutions in organ transplantation and related therapies.

  • Expects to deliver innovative solutions by combining both companies’ capabilities.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Terumo earnings date

Logotype for Terumo Corporation
Q2 202612 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Terumo earnings date

Logotype for Terumo Corporation
Q2 202612 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Terumo Corporation develops, manufactures, and distributes medical devices and services. The company's products include airway management devices such as catheters, cannulas, balloons and valves; minimally invasive surgery systems; infusion systems; cartridges for dialysis machines; intrauterine systems for contraception; endoscopic systems for gastrointestinal endoscopy and bronchoscopy procedures; surgical lasers for eye surgery; films for X-rays or pictures of body organs; imaging apparatus for magnetic resonance images (MRIs) and computed tomography (CT) scans; home transfusion treatment machines; products used in blood conservation therapy such as apheresis machines used to separate blood components such as plasma or platelets from whole blood using centrifugal force. The company is based in Tokyo, Japan.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage